166 related articles for article (PubMed ID: 24021903)
61. Clinical characteristics of Burkitt's lymphoma seen in Kenyan patients.
Mwanda OW
East Afr Med J; 2004 Aug; (8 Suppl):S78-89. PubMed ID: 15622606
[TBL] [Abstract][Full Text] [Related]
62. Hodgkin's disease after treatment for Burkitt's lymphoma: case report.
Kotila TR; Aken'ova YA; Shokunbi WA; Akingbola TS; Fasola FA
East Afr Med J; 2001 Jun; 78(6):334-6. PubMed ID: 12002116
[TBL] [Abstract][Full Text] [Related]
63. A comparison of results achieved in treating two series of patients with Burkitt's lymphoma.
Williams EH
Br J Cancer; 1971 Mar; 25(1):37-45. PubMed ID: 5581300
[TBL] [Abstract][Full Text] [Related]
64. Clinicopathological features of primary thyroid Burkitt's lymphoma: a systematic review and meta-analysis.
Hayashi T; Hirokawa M; Kuma S; Higuchi M; Suzuki A; Kanematsu R; Kudo T; Katsuki N; Haba R; Miyauchi A
Diagn Pathol; 2020 Feb; 15(1):13. PubMed ID: 32035483
[TBL] [Abstract][Full Text] [Related]
65. Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse.
Appelbaum FR; Deisseroth AB; Graw RG; Herzig GP; Levine AS; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
Cancer; 1978 Mar; 41(3):1059-63. PubMed ID: 638947
[TBL] [Abstract][Full Text] [Related]
66. Burkitt's lymphoma in Ibadan: hematologic response to single, large, intravenous dose of cyclophosphamide. Case reports.
Durodola JI
J Natl Med Assoc; 1976 May; 68(3):185-7. PubMed ID: 933184
[No Abstract] [Full Text] [Related]
67. [Burkitt's leukemia presenting as atypical acute mastoiditis in a 7-month-old child].
Vigier S; Nicollas R; Roman S; Barlogis V; Coulibaly B; Triglia JM
Arch Pediatr; 2013 Dec; 20(12):1317-20. PubMed ID: 24176693
[TBL] [Abstract][Full Text] [Related]
68. Clinicopathological analysis of oral Burkitt's lymphoma in pediatric patients: A systematic review.
Rodrigues-Fernandes CI; Pérez-de-Oliveira ME; Aristizabal Arboleda LP; Fonseca FP; Lopes MA; Vargas PA; Santos-Silva AR
Int J Pediatr Otorhinolaryngol; 2020 Jul; 134():110033. PubMed ID: 32302884
[TBL] [Abstract][Full Text] [Related]
69. Burkitt's lymphoma in Ibadan: response to various doses of cyclophosphamide and long-term survivors.
Durodola JI
Eur J Cancer (1965); 1976 Jun; 12(6):425-32. PubMed ID: 954555
[No Abstract] [Full Text] [Related]
70. Retrospective study of childhood burkitts lymphoma in north eastern Nigeria.
Mava Y; Baba UA; Timothy SY; Pius S; Ambe JP
West Afr J Med; 2013; 32(4):297-301. PubMed ID: 24488287
[TBL] [Abstract][Full Text] [Related]
71. Prognostic significance of biochemical markers in African Burkitt's lymphoma.
Arthur FK; Owusu L; Yeboah FA; Rettig T; Osei-Akoto A
Clin Transl Oncol; 2011 Oct; 13(10):731-6. PubMed ID: 21975335
[TBL] [Abstract][Full Text] [Related]
72. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya.
Otieno MW; Remick SC; Whalen C
Int J Cancer; 2001 Jun; 92(5):687-91. PubMed ID: 11340573
[TBL] [Abstract][Full Text] [Related]
73. Survival of Burkitt's lymphoma patients in Mulago Hospital, Uganda.
Morrow RH; Pike MC; Kisuule A
Br Med J; 1967 Nov; 4(5575):323-7. PubMed ID: 6053614
[No Abstract] [Full Text] [Related]
74. Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.
Philip T; Lenoir GM; Bryon PA; Gerard-Marchant R; Souillet G; Philippe N; Freycon F; Brunat-Mentigny M
Br J Cancer; 1982 May; 45(5):670-8. PubMed ID: 7082553
[TBL] [Abstract][Full Text] [Related]
75. Endemic Burkitt Lymphoma: Long-term Outcome in 87 Patients Who Presented With Paraplegia in Cameroon.
Hesseling PB; Mbah G; Kouya F; Kimbi C; Nfor P; Kaah J; Kuruvilla R; Best A; Wharin P
Pediatr Hematol Oncol; 2015; 32(8):525-8. PubMed ID: 26606160
[TBL] [Abstract][Full Text] [Related]
76. Treatment of Burkitt's lymphoma: randomized clinical trial of single-agent versus combination chemotherapy.
Olweny CL; Katongole-Mbidde E; Kaddu-Mukasa A; Atine I; Owor R; Lwanga S; Carswell W; Magrath IT
Int J Cancer; 1976 Apr; 17(4):436-40. PubMed ID: 776840
[TBL] [Abstract][Full Text] [Related]
77. Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.
Mukhtar F; Boffetta P; Risch HA; Park JY; Bubu OM; Womack L; Tran TV; Zgibor JC; Luu HN
Int J Cancer; 2017 Apr; 140(7):1494-1502. PubMed ID: 28006853
[TBL] [Abstract][Full Text] [Related]
78. Intensive chemotherapy for non-localised Burkitt's lymphoma.
Al-Attar A; Pritchard J; Al-Saleem T; Al-Naimi M; Alash N; Attra A
Arch Dis Child; 1986 Oct; 61(10):1013-9. PubMed ID: 3777984
[TBL] [Abstract][Full Text] [Related]
79. Rituximab is highly effective in children and adolescents with Burkitt lymphoma in Risk Groups R2 to R4.
Zhen Z; Zhu J; Wang J; Lu S; Sun F; Huang J; Sun X
Pediatr Hematol Oncol; 2020 Sep; 37(6):489-499. PubMed ID: 32364412
[TBL] [Abstract][Full Text] [Related]
80. Long-term experience with Burkitt's lymphoma in Uganda.
Olweny CL; Katongole-Mbidde E; Otim D; Lwanga SK; Magrath IT; Ziegler JL
Int J Cancer; 1980 Sep; 26(3):261-6. PubMed ID: 7287207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
